DealsArdian reinvests in Neopharmed Gentili alongside NB RenaissanceMediolanum Famaceutici will retain a significant portion of the group’s shareholding.ByDavid Wansboro9 November 2022•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeHealthcareTop Stories